ceric oxide and Obesity
ceric oxide has been researched along with Obesity in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Abd El-Monem, AM; Ali, RH; El Agaty, SM; Galal Hamam, G; Lasheen, NN; Lebda, FM | 1 |
Abdelmottaleb Moussa, SA; Bashandy, SA; El-Seidy, AMA; Elbaset, MA; Ibrahim, FAA | 1 |
Ciofani, G; Giorgi, M; Mattoli, V; Moscato, S; Nitti, S; Rocca, A; Ronca, F | 1 |
Other Studies
3 other study(ies) available for ceric oxide and Obesity
Article | Year |
---|---|
Cerium oxide nanoparticles modulate liver X receptor and short heterodimer partner, and attenuate liver steatosis and steatohepatitis in a rat model of postmenopausal obesity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cerium; Dyslipidemias; Fatty Acids, Nonesterified; Female; Fibrosis; Fructose; Humans; Liver; Liver X Receptors; Malondialdehyde; Nanoparticles; Non-alcoholic Fatty Liver Disease; Obesity; Ovariectomy; Postmenopause; Rats; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |
Nano cerium oxide and cerium/zinc nanocomposites characterization and therapeutic role in combating obesity via controlling oxidative stress and insulin resistance in rat model.
Topics: Animals; Cerium; Cholesterol; Insulin Resistance; Nanocomposites; Nanoparticles; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Rats; Triglycerides; Zinc; Zinc Oxide | 2023 |
Pilot in vivo investigation of cerium oxide nanoparticles as a novel anti-obesity pharmaceutical formulation.
Topics: Adipogenesis; Animals; Cerium; Chemistry, Pharmaceutical; Humans; Insulin; Male; Nanoparticles; Obesity; Oxidative Stress; Rats; RNA, Messenger; Weight Gain | 2015 |